Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibiotics: what's new?

Steven P LaRosa1, Kenneth J Tomecki

  • 1Cleveland Clinic Foundation, Ohio, USA.

Cutis
|June 9, 2004
PubMed
Summary
This summary is machine-generated.

Newer broad-spectrum antibiotics offer effective treatment options for severe skin and skin structure infections caused by resistant pathogens. This review discusses the pharmacologic profiles and clinical roles of three novel antibiotic classes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemopurifier device in patients with solid tumours who have stable or progressive disease while on a treatment that includes pembrolizumab or nivolumab: protocol for an Australian safety, feasibility and dose-finding study.

BMJ open·2026
Same author

Increased mannosylation of extracellular vesicles in Long COVID plasma provides a potential therapeutic target for <i>Galanthus nivalis</i> agglutinin (GNA) affinity resin.

bioRxiv : the preprint server for biology·2025
Same author

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Current Management and Innovative Therapies.

International journal of dermatology·2025
Same author

A lectin affinity plasmapheresis device removes extracellular vesicles and microRNAs from renal perfusates following controlled oxygenated rewarming of discarded donor kidneys.

Transplant immunology·2025
Same author

Removal of clinically relevant SARS-CoV-2 variants by an affinity resin containing Galanthus nivalis agglutinin.

PloS one·2022
Same author

Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection.

Frontiers in medicine·2021
Same journal

Black Dots on the Scalp of a Child.

Cutis·2026
Same journal

Psoriasis and Obesity: A Clinical Review of the Bidirectional Link and Management Implications.

Cutis·2026
Same journal

Adalimumab in Lichen Planus: A Narrative Review of Treatment and Paradoxical Reactions.

Cutis·2026
Same journal

The Future of Psoriasis Care.

Cutis·2026
Same journal

Evaluating GPT-4o for Automated Classification of Skin Lesions Using the HAM10000 Dataset.

Cutis·2026
Same journal

Metastatic Primary Extramammary Paget Disease: A Case Series.

Cutis·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Dermatology

Background:

  • Traditional antibiotics like beta-lactams, macrolides, and clindamycin are standard for skin infections.
  • Increasing antimicrobial resistance necessitates novel therapeutic strategies.
  • Severe skin and skin structure infections (SSSIs) pose significant clinical challenges.

Purpose of the Study:

  • To review the pharmacologic profiles of three newer classes of broad-spectrum antibiotics.
  • To discuss the role of these novel agents in treating SSSIs.
  • To highlight options for managing infections caused by resistant pathogens.

Main Methods:

  • Literature review of pharmacologic data for newer antibiotic classes.
  • Analysis of clinical evidence supporting their use in SSSIs.

Related Experiment Videos

  • Discussion of mechanisms of action and spectrum of activity.

    • Main Results:

    • Three distinct classes of newer broad-spectrum antibiotics demonstrate efficacy against resistant pathogens.
    • These agents possess favorable pharmacologic profiles for treating SSSIs.
    • Clinical data support their utility in specific SSSI scenarios.

    Conclusions:

    • Novel broad-spectrum antibiotics represent valuable additions to the SSSI treatment armamentarium.
    • Understanding their pharmacologic properties is crucial for optimal clinical application.
    • These agents are important for combating infections caused by drug-resistant bacteria.